MedrxMedrx Co., Ltd.4586東証グロース医薬品FY ending Dec 2025, consolidated, J-GAAP

Medrx FY ending Dec 2019 results

Medrx brought in ¥169.9M in revenue.

It lost about ¥958 for every ¥100 of sales at the operating level.

Where the money goes

For every ¥100 Medrx sells, how much goes where, and how much is kept.

FY ending Dec 2019

Margin funnel (derived from reported values)Gross margin 96.9% → Operating margin -958.4% → Net margin -951.6%

Show source documents (3)

EDINET (FSA Japan)
有価証券報告書－第22期(2023/01/01－2023/12/31)
ID S100T6BL2024-03-29Open
EDINET (FSA Japan)
有価証券報告書－第20期(令和3年1月1日－令和3年12月31日)
ID S100NT3I2022-03-31Open
EDINET (FSA Japan)
訂正有価証券報告書－第19期(令和2年1月1日－令和2年12月31日)
ID S100LCUR2021-05-18Open

Extracted from XBRL: 33 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.